Friday, March 23, 2018 12:04:17 PM
And with regards to CLI, again I am not necessarily meaning off label. Just something in regards to all the changes that have and are taking place in the approval process. Through all the proper channels, they have a chance to make it through much easier with some good results in the CLI based measures.
And would the amputation rate be based on the DFU results. If they cure or help the ulcer, would that rate not go down? With no other treatment options, why wouldn't a physician look into other possible treatments, especially if the safety factor is taken out of the equation.
All I'm saying is these fast track and other designations, are not the best for companies like ours, who have spent years going through the proper process, only for some like Celularity to catch up in a much shorter timeframe. Do you not think the ex FDA commissioner on their board, along with many others, increases their chances of success? They use the same sourced cells.
Like I said before, going it alone with be the death sentence of this company imo. In the very least, decreases our chances substantially. Hopefully IC results will get us a big Pharma partner finally. I sure hope we get these in April. Time will tell.
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM